Cargando…
Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
BACKGROUND: Bronchopulmonary dysplasia (BPD) is among the most severe chronic lung diseases and predominantly affects premature infants. There is a general understanding of BPD’s significant impact on the short-term outcomes however there is little evidence on long-term outcomes. Our study estimates...
Autores principales: | van Katwyk, Sasha, Augustine, Sajit, Thébaud, Bernard, Thavorn, Kednapa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093972/ https://www.ncbi.nlm.nih.gov/pubmed/32213174 http://dx.doi.org/10.1186/s12887-020-02037-5 |
Ejemplares similares
-
Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)
por: Thébaud, Bernard, et al.
Publicado: (2021) -
Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
por: Wang, Xuting, et al.
Publicado: (2022) -
Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta‐Analysis of Preclinical Studies
por: Augustine, Sajit, et al.
Publicado: (2017) -
Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
por: Onland, Wes, et al.
Publicado: (2018) -
Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019)